Sanofi bid first, but Bio­gen won out in fight to ac­quire Rea­ta — re­port 

Sanofi was the mys­tery “Par­ty A” that en­gaged in a bid­ding war with Bio­gen for the $7.3 bil­lion buy­out of Rea­ta Phar­ma­ceu­ti­cals, ac­cord­ing to a Bloomberg News re­port, cit­ing un­named sources.

The French Big Phar­ma bid for Rea­ta first, but its for­mer CEO Chris Viehbach­er and his busi­ness de­vel­op­ment team at Bio­gen pre­vailed in the deal talks and won by a slim 50 cent-per-share mar­gin. A Sanofi spokesper­son de­clined to com­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER